Ebola virus antibody decay–stimulation in a high proportion of survivors

Journal: Nature

Published: 2021-01-27

DOI: 10.1038/s41586-020-03146-y

Affiliations: 31

Authors: 55

Go to article
Institutions Share
Sierra Leone Ministry of Health and Sanitation, Sierra Leone 0.11
Public Health England (PHE), United Kingdom (UK) 0.09
University of Sierra Leone (USL), Sierra Leone 0.09
University of Liverpool, United Kingdom (UK) 0.08
Institute of Tropical Medicine (ITM), Belgium 0.07
NIHR Health Protection Research Unit in Emerging and Zoonotic Infections (NIHR HPRUEZI), United Kingdom (UK) 0.07
NHS Blood and Transplant (NHSBT), United Kingdom (UK) 0.06
University of Oxford, United Kingdom (UK) 0.05
London School of Hygiene and Tropical Medicine (LSHTM), United Kingdom (UK) 0.05
King’s Health Partners, United Kingdom (UK) 0.04
World Health Organization (WHO), Switzerland 0.04
The University of North Carolina at Chapel Hill (UNC), United States of America (USA) 0.04
Health Protection Scotland (HPS), United Kingdom (UK) 0.02
University of Birmingham (UB), United Kingdom (UK) 0.02
Liverpool School of Tropical Medicine (LSTM), United Kingdom (UK) 0.02
34th Regimental Military Hospital, Sierra Leone 0.02
GlaxoSmithKline plc. (GSK), United Kingdom (UK) 0.02
Physio Fitness Rehabilitation Centre, Sierra Leone 0.02
Charité - University Medicine Berlin, Germany 0.02
University of Exeter, United Kingdom (UK) 0.02
The Roslin Institute, The University of Edinburgh, United Kingdom (UK) 0.02
Clinical Research Management, Inc. (ClinicalRM), United States of America (USA) 0.02
Duke University Health System, United States of America (USA) 0.02
MRC-University of Glasgow Centre for Virus Research (CVR), United Kingdom (UK) 0.01